In order to promote academic exchanges and experience sharing in standardized diagnosis and treatment of tumors, promote the standardization and standardization process of tumor diagnosis and treatment in China, and gradually realize standardization, specialization, standardization, refinement and informatization, and ultimately benefit the majority of patients. Chengdu High-tech Medical Association successfully held the "Progress of Immunotherapy for Non-small Cell Lung Cancer and Standardized Tumor Immunotherapy Tour" online on May 15, 2022.

The conference was hosted by Chengdu High-tech Medical Association, and invited well-known domestic experts in the field of tumor immunology to give special academic reports, and discuss and exchange classic cases and cutting-edge technologies of related specialties.

This conference provides a platform for the exchange of diagnosis and treatment technology and academic scientific research results for the majority of clinical doctors and researchers, which is conducive to promoting the academic development of clinical research and medical tumor immunology, and is of great significance for promoting high-quality clinical research and promoting the level of clinical research in the field of medical tumor immunology.